- Open Access
Invasion of Africa by a single pfcrt allele of South East Asian type
© Ariey et al; licensee BioMed Central Ltd. 2006
Received: 05 January 2006
Accepted: 26 April 2006
Published: 26 April 2006
Because of its dramatic public health impact, Plasmodium falciparum resistance to chloroquine (CQ) has been documented early on. Chloroquine-resistance (CQR) emerged in the late 1950's independently in South East Asia and South America and progressively spread over all malaria areas. CQR was reported in East Africa in the 1970's, and has since invaded the African continent. Many questions remain about the actual selection and spreading process of CQR parasites, and about the evolution of the ancestral mutant gene(s) during spreading.
Eleven clinical isolates of P. falciparum from Cambodia and 238 from Africa (Senegal, Ivory Coast, Bukina Faso, Mali, Guinea, Togo, Benin, Niger, Congo, Madagascar, Comoros Islands, Tanzania, Kenya, Mozambique, Cameroun, Gabon) were collected during active case detection surveys carried out between 1996 and 2001. Parasite DNA was extracted from frozen blood aliquots and amplification of the gene pfcrt exon 2 (codon 72–76), exon 4 and intron 4 (codon 220 and microsatellite marker) were performed. All fragments were sequenced.
124 isolates with a sensitive (c76/c220:CVMNK/A) haplotype and 125 isolates with a resistant c76/c220:CVIET/S haplotype were found. The microsatellite showed 17 different types in the isolates carrying the c76/c220:CVMNK/A haplotype while all 125 isolates with a CVIET/S haplotype but two had a single microsatellite type, namely (TAAA)3(TA)15, whatever the location or time of collection.
Those results are consistent with the migration of a single ancestral pfcrt CQR allele from Asia to Africa. This is related to the importance of PFCRT in the fitness of P. falciparum point out this protein as a potential target for developments of new antimalarial drugs.
The molecular basis of chloroquine resistance has recently been elucidated. Pfcrt (Plasmodium falciparum chloroquine resistance transporter), a single copy, 13-exon gene, localized on chromosome 7, codes for a parasite digestive vacuole trans-membrane protein, which plays a key role in CQR [1, 2]. The pfcrt gene appears to be polymorphic and more than 20 different amino-acid sequences have been identified [3–5]. Recent genome wide microsatellite scanning has shown marked linkage disequilibrium around the pfcrt locus and pointed to four distinct founder events, with one ancestral mutant originating in Asia and subsequently invading Africa . The evolution of this mutant after its local emergence and its spread across Africa has not been studied.
Eleven clinical isolates of P. falciparum from Cambodia, 112 from West and Central Africa (Senegal, Ivory Coast, Bukina Faso, Mali, Guinea, Togo, Benin, Niger, Congo) and 126 from East and South Africa (Madagascar, Comoros Islands, Tanzania, Kenya, Mozambique, Cameroun, Gabon) were collected during active case detection surveys carried out between 1996 and 2001. Briefly, 5 mL blood samples were collected in EDTA vacutainers from patients diagnosed as having uncomplicated P. falciparum malaria. Immediately after blood collection, the patients were treated according to national recommendations. Blood samples were kept at 4°C for in vitro drug sensitivity testing. An aliquot of each isolate was frozen at -20°C for molecular analysis. Informed consent was obtained from the patients. Ethical clearance was obtained from the respective National Ethical Commitees.
DNA extraction, PCR analysis and sequencing
Parasite DNA was extracted from frozen blood aliquots by the phenol-chloroform method as described previously . The pfcrt haplotype was determined by sequencing PCR fragments, amplified from single clone infections (as determined using msp2 amplification profiles see  for detail) using two sets of primers designed to amplify a 194 bp exon 2 fragment (CRT76-sense 5'-GGTGGAGGTTCTTGTCTTGG-3 and CRT76-antisense 5'-ATAAAGTTGTGAGTTTCGGATG-3') and 309 bp fragment from exon 4 to exon 5 (CRT220-sense 5'-TTATACAATTATCTCGGAGCAG-3' and CRT220-antisense 5'-CATGTTTGAAAAGCATACAGGC-3'). The primers were selected on the basis of the sequence of the pfcrt gene of the Dd2 clone (accession number AF030694). PCR was performed in a PTC-100 thermal cycler (MJ Research, Merck Eurolab) under the following conditions: 50 μL final volume containing 2 μL DNA, 200 μM each dNTP, 0.5 μM each primer, 2 mM MgCl2, and 2 U Taq I DNA polymerase (Promega) in the buffer supplied by the manufacturer.
The amplification conditions were: 1 min at 95°C, 1 min 30 at 59°C, and 1 min at 72°C for 1 cycle; 10 s at 95°C, 1 min 30 at 59°C, and 2 min at 72°C for 35 cycles, and a final extension step at 72°C for 10 min. The resulting PCR products contained codons 76 and 220 as well as intron 4, respectively. All fragments were subjected to gel electrophoresis on agarose gels containing ethidium bromide and were sequenced using the fluorescent dye terminator method as described in . The multiple infections still found on the basis of sequencing of the microsatelittes were discarded from the analysis (two Cambodian and six African isolates). Each sequence was analysed using Chromas® v 1.45 software.
The strikingly different microsatellite distribution in isolates carrying a resistant or a sensitive haplotype was highly significant (chi-square test P < 0.00001). Intron 4 microsatellite field polymorphism is such that the observation of a single allelic form in all but two isolates carrying a resistant haplotype cannot be explained by chance. This indicates that the resistant CVIET/S haplotype is indeed ear-marked by a specific intragenic microsatellite, and points to the existence of a single progenitor allelic form for this locus in African areas investigated here. This represents a strong population genetic evidence for an absence of endogenous emergence of a resistant allele in Africa. It demonstrates the migration of one single CVIET/S pfcrt allele from South East Asia into Africa and its subsequent spreading throughout the whole African continent.
Interestingly, a similar analysis on 15 CQR isolates from French Guiana showed that the typical South American (SVMNT/S) resistant haplotype was also associated with a single (TAAA)3(TA)14 microsatellite type, that differed from the (TAAA)3(TA)15 observed in African and Asian CQR isolates. This indicates that the microsatellite sequence itself has limited phenotypic impact and is reminiscent with the association of resistant pfcrt haplotypes with specific intron 4 microsatellites. This shows that resistant haplotypes that have emerged independently in Asia and in South America more than 30 years ago have limited local diversity nowadays.
Why did resistant parasites emerge in Asia/America and not in Africa, despite the larger size of the overall African P. falciparum population?
One of the explanations could be that there is higher P. falciparum mutation rate in Asia/America than in Africa . But, if so, after two decades without CQ pressure in Asia/America, falciparum pfcrt would have "reversed" to the wild type allele, since the appearance of resistant strains occurred at the very beginning of the introduction of chloroquine on a large scale. The latest studies, that were performed in Asia/America, show no reappearance of wild type pfcrt strains, invalidate this hypothesis .
Most likely, this emergence can be attributed to differences in transmission conditions and population structure. The endemic areas in South East Asia and South America can be considered as "localized permanent epidemics" , with a metapopulation structure for the P. falciparum populations, in which forces acting on differentiation are more effective than in Africa . Indeed population isolation is thought to lead to an increased parasite diversity or local sub-speciation. In a subpopulation of a small number of parasites, genetic drift will act as a major force. This will increase polymorphism on coding sequence without any link with the possible fitness of the selected allele (this also as been shown for cytochrome b sequence in Asia/America compared to Africa ). When CQ pressure increased, some pfcrt alleles associated with low fitness in CQ free environment will become associated with a high fitness in this CQ environment and could thus invade the African parasite population. If CQ pressure stops, and if the ''wild type allele" is still present in the subpopulation, it will replace the mutant allele (studies in Malawi show that the relative fitness of the mutant pfcrt allele in the absence of CQ pressure is 0.76 or 0.86 [15, 16]).
Field isolates collected from clinical cases confirm that the current continent-wide CQR in Africa is due to the invasion of a single mutant allele. Therefore, monitoring the gene flow regionally can provide valuable information in assessing selection of candidate resistance gene by selective drug pressure for other antimalarials or vaccine escape.
Moreover, despite the overall PfCRT protein polymorphisms described so far in Asia , only one major allele has invaded Africa. This can probably be explain by the importance of this protein in the fitness of the parasite and thus to the difficulty for a pfcrt mutant to be selected in CQ-free area of high transmission where fierce competition occurs between strains. This strongly suggest that pfcrt is still one of the major potential target for antimalarial drugs and reinforces the need for a better understanding of its role in Plasmodium metabolism .
This work was funded by the French Academy of Sciences and the FSP-RAI project from the French government. We are indebted to the field workers (physicians, nurses and technicians) for participation in collecting parasitized blood samples.
- May J, Meyer CG: Chemoresistance in falciparum malaria. Trends Parasitol. 2003, 19: 432-435. 10.1016/j.pt.2003.08.001.View ArticlePubMedGoogle Scholar
- Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE: Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000, 6: 861-871. 10.1016/S1097-2765(05)00077-8.PubMed CentralView ArticlePubMedGoogle Scholar
- Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002, 418: 320-323. 10.1038/nature00813.View ArticlePubMedGoogle Scholar
- Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, Denis MB, Hewitt S, Hoyer S, Socheat D, Merecreau-Puijalon O, Fandeur T: pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Agents Chemother. 2003, 47: 87-94. 10.1128/AAC.47.1.87-94.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Uhleman AC, Yuthavong Y, Fidock DA: Mechanisms of antimalarial drug action and resistance. Molecular approaches to malaria. Edited by: Sherman IW. 2005, Washington DC. ASM Press, 429-461.View ArticleGoogle Scholar
- Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA, Zimmerman PA: Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci U S A. 2001, 98: 12689-12694. 10.1073/pnas.221440898.PubMed CentralView ArticlePubMedGoogle Scholar
- Waller Karena, Lee Sylvia, Fidock David: Molecular and Cellular Biology of Chloroquine Resistance in Plasmodium falciparum. Genomes and Molecular Biology. Edited by: Waters AP, CJ Janse Leiden. 2004, Chapter 16:Google Scholar
- Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-Puijalon O: PCR typing of field isolates of Plasmodium falciparum. J Clin Microbiol. 1995, 33: 944-951.PubMed CentralPubMedGoogle Scholar
- Ariey F, Randrianarivelojosia M, Duchemin JB, Rakotondramarina D, Ouledi A, Robert V, Jambou R, Jahevitra M, Andrianantenaina H, Raharimalala L, Mauclere P: Mapping of a Plasmodium falciparum pfcrtK76T mutation: a useful strategy for controlling chloroquineresistance in Madagascar. J Infect Dis. 2002, 185: 710-712. 10.1086/339000.View ArticlePubMedGoogle Scholar
- Rathod PK, McErlean T, Lee PC: Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A. 1997, 94: 9389-9393. 10.1073/pnas.94.17.9389.PubMed CentralView ArticlePubMedGoogle Scholar
- Verdrager J: Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 1995, 26: 23-28.PubMedGoogle Scholar
- Ariey F, Duchemin JB, Robert V: Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. Infect Genet Evol. 2003, 2: 185-192. 10.1016/S1567-1348(02)00099-0.View ArticlePubMedGoogle Scholar
- Ekala M, Legrand E, Kim N, Randrianarivelojosia M, Jambou R, Fandeur T, Ariey F, Bouchier C, Mercereau Puijalon O: Sequencevariations of Plasmodium falciparum cytochrome b in field isolates from a multicentric study. Abstract MIM-ME-142462 Yaounde Cameroun. 2005Google Scholar
- Mita T, Kaneko A, Lum JK, Zungu IL, Tsukahara T, Eto H, Kobayakawa T, Bjorkman A, Tanabe K: Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol. 2004, 135: 159-163. 10.1016/j.molbiopara.2004.01.011.View ArticlePubMedGoogle Scholar
- Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV: Reemergence ofchloroquine-sensitive Plasmodium falciparum malaria aftercessation of chloroquine use in Malawi. J Infect Dis. 2003, 187: 1870-1875. 10.1086/375419.View ArticlePubMedGoogle Scholar
- Cortese JF, Caraballo A, Contreras CE, Plowe CV: Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis. 2002, 186: 999-1006. 10.1086/342946.View ArticlePubMedGoogle Scholar
- Cooper RA, Hartwig CL, Ferdig MT: pfcrt is morethan the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop. 2005, 94: 170-180.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.